The Enterprise Value as of December 2025 (TTM) for Pear Therapeutics, Inc. (PEARW) is -6605182.00

According to Pear Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -6605182.00. This represents a change of -102.09% compared to the average of 316.35M of the last 4 quarters.

Pear Therapeutics, Inc. (PEARW) Historical Enterprise Value (quarterly & annually)

How has PEARW Enterprise Value performed in the past?

The mean historical Enterprise Value of Pear Therapeutics, Inc. over the last ten years is 843.05M. The current -6605182.00 Enterprise Value has changed -178.35% with respect to the historical average. Over the past ten years (40 quarters), PEARW's Enterprise Value was at its highest in in the December 2021 quarter at 685.46M. The Enterprise Value was at its lowest in in the December 2020 quarter at -84555000.00.

Pear Therapeutics, Inc. (PEARW) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pear Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pear Therapeutics, Inc. (PEARW) Average Enterprise Value

How has PEARW Enterprise Value performed in the past?

The current Enterprise Value of Pear Therapeutics, Inc. (PEARW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Pear Therapeutics, Inc. (PEARW) Enterprise Value vs. Peers

How is PEARW’s Enterprise Value compared to its peers?

Pear Therapeutics, Inc.’s Enterprise Value is less than Ra Medical Systems, Inc. (6.24M), less than Hillstream BioPharma, Inc. (1.93M), less than Altamira Therapeutics Ltd. (495.99K), less than Xylo Technologies Ltd. (1.88M), less than TNF Pharmaceuticals, Inc. (8.98M), less than Gamida Cell Ltd. (40.73M), less than Xylo Technologies Ltd. (1.88M), less than UpHealth, Inc. (147.26M), less than Aptose Biosciences Inc. (4.06M), less than Gritstone bio, Inc. (43.29M),

Build a custom stock screener for Pear Therapeutics, Inc. (PEARW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pear Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pear Therapeutics, Inc. (PEARW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pear Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.